
99%+ Purity
COA Included
Sealed Vials
CJC-1295 (DAC)
Long-acting GHRH analog for sustained GH elevation
Long GH elevation
Key Benefits
- Extended growth hormone elevation for days
- Stimulates natural pituitary hormone production
- Innovative albumin-binding sustained-release technology
- May support consistent IGF-1 levels
- Less frequent dosing requirements
- Works through body's natural hormone pathways
- Research-grade peptide for serious investigators
Growth Hormone That Works for Days, Not Hours
Most GH protocols require daily injections and create hormone spikes that crash just as fast as they rise. CJC-1295 DAC changes the game completely—one injection delivers sustained growth hormone elevation for days, not hours. You get consistent anabolic signaling without the rollercoaster, which means better recovery, more stable energy, and results that actually compound over time.
Pituitary somatotroph / GHRH receptor pathway (sustained cAMP-mediated GH release)
About CJC-1295 (DAC)
CJC-1295 DAC is a long-acting growth hormone releasing hormone analog that binds to albumin in your bloodstream, extending its active life from minutes to days. Instead of directly injecting growth hormone, it stimulates your pituitary gland to produce and release more of its own GH through natural pathways. The result is sustained, consistent elevation of both growth hormone and IGF-1 levels with significantly less frequent dosing.
Who It's For
This is the peptide for serious practitioners who understand that consistency trumps intensity when it comes to growth hormone optimization. The extended-release mechanism makes it particularly valuable for those seeking steady anabolic support without the complexity of daily injection protocols. CJC-1295 DAC works best as a foundational element in long-term body composition and recovery strategies where sustained hormonal elevation provides cumulative benefits over months, not weeks.
Research Background
CJC-1295 DAC represents an innovative approach to growth hormone therapy that leverages the body's natural hormone regulation systems. Rather than directly injecting growth hormone, this peptide works by stimulating the pituitary gland to produce and release more of its own growth hormone through activation of specific receptors. The key innovation lies in its albumin-binding technology, which allows the peptide to remain active in the bloodstream for days rather than minutes.
Research has primarily focused on: 1) Understanding how the albumin-binding mechanism affects the duration and consistency of growth hormone elevation, 2) Investigating potential therapeutic applications for growth hormone deficiency states, and 3) Exploring the safety profile of sustained versus pulsatile GH stimulation. However, it's important to note that clinical research remains limited, with most published studies focusing on the underlying mechanisms rather than comprehensive human trials. The scientific community continues to investigate both the therapeutic potential and long-term safety considerations of this extended-release approach to growth hormone modulation.
Dosing Protocol
| Level | Dose | |
|---|---|---|
Beginner | 0.25 mg/week | |
Intermediate | 0.5 mg/week | |
Advanced | 1-2 mg/week | |
Maximum | 4-5 mg/week |
Select a dosing level and click Calculate to plan your protocol.
Vials Required
2
6.0 mg needed ÷ 5 per vial
Total Investment
$120
$60.00 per vial
Per Dose
0.20 mL
20 units on U-100 syringe
Doses per Vial
10
5 ÷ 0.50 mg/dose
* Calculations based on standard reconstitution protocols. Consult research guidelines for specific applications.
Compliance & Disclaimer
This product is intended for laboratory research purposes only. Not for human consumption. All products are sold with the understanding that the purchaser will comply with all applicable local, state, and federal laws regarding the purchase and use of research chemicals. Certificate of Analysis available upon request.
Related Products

CJC-1295 (No DAC)
GHRH analog for pulsatile GH release

CJC-1295 / Ipamorelin
CJC-1295 and Ipamorelin are designed for clients who want measurable performance, recovery, and longevity benefits—without crossing the line into hormone replacement or system shutdown. This is not synthetic HGH and it’s not a short-term hack. It’s a disciplined, physiology-first approach that restores the body’s own growth hormone signaling, which naturally declines with age, stress, poor sleep, and overtraining. CJC-1295 works upstream at the pituitary level, enhancing the quality, duration, and consistency of natural GH release, while Ipamorelin acts as a precision trigger—stimulating GH without the cortisol spikes, prolactin elevation, or hunger issues associated with older compounds. Together, they create smoother, more youthful GH pulses that the body actually knows how to use. From a client experience standpoint, this shows up where it matters: deeper, more restorative sleep; faster recovery between workouts or long workdays; improved fat metabolism; better skin and tissue quality; and a noticeable improvement in overall resilience. There’s no suppression of natural production, no dependency risk, and no hormonal rollercoaster—making it appropriate for long-term use and scalable protocols. For many clients, this stack becomes the foundation layer they build everything else on, because it improves how the body repairs, adapts, and recovers across the board. In short, this is growth hormone optimization for adults who play the long game—subtle, sustainable, and designed to deliver compounding returns over time.

Fragment 176-191
HGH fat-burning fragment
CJC-1295 (DAC)
$60.00